FWM
AMED

FSA Wealth Management’s Amedisys AMED Stock Holding History

FSA Wealth Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10
Closed -$984 – 574
2025
Q2 		$984 Hold
10
– – ﹤0.01% 506
2025
Q1 		$926 Hold
10
– – ﹤0.01% 475
2024
Q4 		$908 Hold
10
– – ﹤0.01% 529
2024
Q3 		$965 Buy
+10
New +$976 ﹤0.01% 527
2024
Q1 		$922 Hold
10
– – ﹤0.01% 579
2023
Q4 		$1K Buy
+10
New +$934 ﹤0.01% 548

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

FSA Wealth Management's AMED Position: Q3 2025 in Review

FSA Wealth Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 10 shares — an estimated $984 sold.

FSA Wealth Management first reported a position in AMED in Q4 2023 and held it in 6 quarters. The position peaked at $1K in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • FSA Wealth Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • FSA Wealth Management sold 10 Amedisys shares in Q3 2025, an estimated $984.
  • FSA Wealth Management first reported a position in Amedisys in Q4 2023 and held it in 6 quarters.
  • FSA Wealth Management's Amedisys position peaked at $1K in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.